Arteriovenous malformations (AVMs) are tangles of abnormal blood vessels connecting arteries and veins, which disrupt normal blood flow and oxygen circulation. The Arteriovenous Malformations Market primarily comprises endovascular embolization devices, stereotactic radiosurgery systems, and surgical instruments for AVM management. Embolization materials—such as coils, liquid embolic agents, and detachable plugs—offer targeted vessel occlusion with reduced risk of surrounding tissue damage.

Arteriovenous Malformations Market Advantages include shorter hospital stays, lower complication rates, and faster patient recovery compared to open surgery. Advances in imaging guidance (e.g., 3D rotational angiography) and delivery catheters improve treatment precision. Growing incidence of AVMs, driven by better diagnostic capabilities and rising awareness among healthcare providers, underscores the need for diverse product portfolios with enhanced safety profiles. In addition, increasing preference for outpatient procedures and cost-containment pressures in healthcare systems are fueling the adoption of minimally invasive AVM therapies. Global players are expanding R&D efforts to introduce novel embolic formulations and navigation tools that address challenging lesion anatomies.

According to CoherentMI, The arteriovenous malformations market is estimated to be valued at USD 3.36 Bn in 2025 and is expected to reach USD 4.99 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2032.

Get more insights on: Arteriovenous Malformations Market

Get this Report in Japanese Language: 動静脈奇形市場

Get this Report in Korean Language: 동정맥기형시장